Asthma control in asthmatics treated with extrafine or non-extrafine ICS/LABA combinations in real life setting

被引:0
|
作者
Nicolini, Gabriele
Terzano, Claudio
Cremonesi, Giovanni
Girbino, Giuseppe
Ingrassia, Eleonora
Marsico, Serafino
Allegra, Luigi
机构
[1] Chiesi Farmaceut, Med Affairs, Parma, Italy
[2] Univ Roma La Sapienza, Resp Dis Unit, I-00185 Rome, Italy
[3] Univ Messina, Inst Resp Med, Messina, Italy
[4] Univ Naples 2, Azienda Osped Monaldi, Dept Resp Med, Naples, Italy
[5] Univ Milan, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Thoracopulm Dept, Milan, Italy
关键词
Asthma; -; management; Longitudinal study; Monitoring;
D O I
暂无
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
609
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Impact of Extrafine Formulation Single-inhaler Triple Therapy on Asthma Control and HRQoL After 1 Year: TriMaximize-A Real-world View in Asthma Therapy from Austria
    Sator, L.
    Voves, R.
    Hoermannstorfer-Fessl, K.
    Keckeis, A.
    Tiefenbacher, F.
    Ambrosch, G.
    Wuertz, M.
    Feizelmeier, H.
    Petrovic, M.
    Nevels, R.
    Pohl, W.
    WIENER KLINISCHE WOCHENSCHRIFT, 2024, 136 : S541 - S541
  • [42] Asthma control with extrafine-particle hydrofluoroalkane-beclometasone vs. large-particle chlorofluorocarbon-beclometasone: a real-world observational study
    Barnes, N.
    Price, D.
    Colice, G.
    Chisholm, A.
    Dorinsky, P.
    Hillyer, E. V.
    Burden, A.
    Lee, A. J.
    Martin, R. J.
    Roche, N.
    von Ziegenweidt, J.
    Israel, E.
    CLINICAL AND EXPERIMENTAL ALLERGY, 2011, 41 (11): : 1521 - 1532
  • [43] The effect of smoking on severity of asthma and quality of life in patients treated with inhaled corticosteroids and long-acting b2-agonist (ICS/LABA)
    Sergeeva, Galina
    Emelyanov, Alexander
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [44] Association between the Asthma Control and Health-Related Quality of Life after Six Months of Treatment with Extrafine Single-Inhaler Triple Therapy in TriMaximize Study
    Greulich, T.
    Bogoevska, V
    Nachtigall, D.
    Akyildiz, B.
    Licht, B.
    Slawinska, R.
    Gessner, C.
    PNEUMOLOGIE, 2024, 78 : S4 - S5
  • [45] TriOptimize VII: Improvement of health-related quality of life after 3 months treatmentwith extrafine single inhaler triple therapy in COPD patients in a real-world setting
    Gessner, Christian
    Javan, Sanaz Bahari
    Hoevelmann, Raimund
    Georges, George
    Melchior, Kai
    Criee, Carl-Peter
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [46] Association between serum leptin and control of asthma in adult Lebanese atopic asthmatics: A real-life study
    Irani, C.
    Kozaily, E.
    Fares, N.
    Hajal, J.
    Sleilaty, G.
    ALLERGY, 2018, 73 : 667 - 667
  • [47] Benralizumab leads to sustained asthma control improvement after 1 year in real-life severe asthmatics
    Renner, A.
    Marth, K.
    Patocka, K.
    Idzko, M.
    Pohl, W.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [48] Asthma Control in Patients with Severe Eosinophilic Asthma Treated with Reslizumab: Spanish Real-Life Data
    de Llano, Luis A. Perez
    Cosio, Borja G.
    Astiarraga, Ignacio Lobato
    Campos, Gregorio Soto
    Alonso, Miguel Angel Tejedor
    Malanda, Nuria Marina
    Galo, Alicia Padilla
    Landa, Isabel Urrutia
    de la Rosa, Francisco J. Michel
    Garcia-Moguel, Ismael
    JOURNAL OF ASTHMA AND ALLERGY, 2022, 15 : 79 - 88
  • [49] Impact of Extrafine Formulation Single-inhaler Triple Therapy on Asthma Control and Health-related Quality of Life After Three Months of Treatment in Patients With Asthma: Trimaximize - A Real-world View From Germany, United Kingdom, Austria and Denmark
    Gessner, C.
    Akyildiz, B.
    Pohl, W.
    Nachtigall, D.
    Russell, R.
    Bogoevska, V.
    Ulrik, C. S.
    Watz, H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [50] Short and long-term quality of life and asthma control with omalizumab therapy in a real life setting in Portugal
    Vieira, T.
    de Oliveira, J. F.
    da Graca Castel-Branco, M.
    ALLERGOLOGIA ET IMMUNOPATHOLOGIA, 2014, 42 (01) : 3 - 10